227 related articles for article (PubMed ID: 17113290)
1. Identification of the benzodiazepines as a new class of antileishmanial agent.
Clark RL; Carter KC; Mullen AB; Coxon GD; Owusu-Dapaah G; McFarlane E; Duong Thi MD; Grant MH; Tettey JN; Mackay SP
Bioorg Med Chem Lett; 2007 Feb; 17(3):624-7. PubMed ID: 17113290
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of indolyl glyoxylamides as a new class of antileishmanial agents.
Chauhan SS; Gupta L; Mittal M; Vishwakarma P; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2010 Nov; 20(21):6191-4. PubMed ID: 20850302
[TBL] [Abstract][Full Text] [Related]
3. Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy.
Carter KC; Hutchison S; Boitelle A; Murray HW; Sundar S; Mullen AB
Parasitology; 2005 Dec; 131(Pt 6):747-57. PubMed ID: 16336728
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.
Tiwari A; Kumar S; Shivahare R; Kant P; Gupta S; Suryawanshi SN
Bioorg Med Chem Lett; 2015 Jan; 25(2):410-3. PubMed ID: 25475205
[TBL] [Abstract][Full Text] [Related]
5. An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani.
Neal RA; Croft SL
J Antimicrob Chemother; 1984 Nov; 14(5):463-75. PubMed ID: 6096347
[TBL] [Abstract][Full Text] [Related]
6. Antileishmanial activity of drug infused mini-agar plates on Leishmania donovani promastigotes.
Muniaraj M; Sinha PK; Das P
Trop Biomed; 2010 Dec; 27(3):657-61. PubMed ID: 21399608
[TBL] [Abstract][Full Text] [Related]
7. Leishmania donovani: effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate.
Valiathan R; Dubey ML; Mahajan RC; Malla N
Exp Parasitol; 2006 Oct; 114(2):103-8. PubMed ID: 16616137
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, cytotoxicity, and in vitro antileishmanial activity of mono-t-butyloxycarbonyl-protected diamines.
Pinheiro AC; Rocha MN; Nogueira PM; Nogueira TC; Jasmim LF; de Souza MV; Soares RP
Diagn Microbiol Infect Dis; 2011 Nov; 71(3):273-8. PubMed ID: 21907525
[TBL] [Abstract][Full Text] [Related]
9. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME
Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
[TBL] [Abstract][Full Text] [Related]
10. Aryloxy cyclohexyl imidazoles: a novel class of antileishmanial agents.
Srinivas N; Palne S; Nishi ; Gupta S; Bhandari K
Bioorg Med Chem Lett; 2009 Jan; 19(2):324-7. PubMed ID: 19091566
[TBL] [Abstract][Full Text] [Related]
11. Effect of sodium stibogluconate on hepatic mixed function oxidase system and marker enzymes of golden hamsters during Leishmania donovani infection.
Mittal N; Gupta N; Goyal N; Singh AK; Guru PY; Pandey VC; Rastogi AK
Indian J Exp Biol; 1997 Apr; 35(4):393-6. PubMed ID: 9315242
[TBL] [Abstract][Full Text] [Related]
12. In vitro interactions between sitamaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani.
Seifert K; Munday J; Syeda T; Croft SL
J Antimicrob Chemother; 2011 Apr; 66(4):850-4. PubMed ID: 21393188
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents.
Esteves MA; Fragiadaki I; Lopes R; Scoulica E; Cruz ME
Bioorg Med Chem; 2010 Jan; 18(1):274-81. PubMed ID: 19926293
[TBL] [Abstract][Full Text] [Related]
14. In vitro antileishmanial activity of inhibitors of steroid biosynthesis and combinations of antileishmanial agents.
Berman JD; Gallalee JV
J Parasitol; 1987 Jun; 73(3):671-3. PubMed ID: 3037057
[No Abstract] [Full Text] [Related]
15. Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani.
Gupta L; Sunduru N; Verma A; Srivastava S; Gupta S; Goyal N; Chauhan PM
Eur J Med Chem; 2010 Jun; 45(6):2359-65. PubMed ID: 20371140
[TBL] [Abstract][Full Text] [Related]
16. Remarks on identification of amplified fragment length polymorphisms linked to SAG resistance in Leishmania.
Van der Auwera G; Bhattarai NR; Odiwuor S; Vuylsteke M
Acta Trop; 2010 Jan; 113(1):92-3. PubMed ID: 19800857
[No Abstract] [Full Text] [Related]
17. Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages.
Berman JD; Lee LS
J Parasitol; 1984 Apr; 70(2):220-5. PubMed ID: 6088749
[TBL] [Abstract][Full Text] [Related]
18. Arylanthranilodinitriles: a new biaryl class of antileishmanial agents.
Singh FV; Vatsyayan R; Roy U; Goel A
Bioorg Med Chem Lett; 2006 May; 16(10):2734-7. PubMed ID: 16503140
[TBL] [Abstract][Full Text] [Related]
19. The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis.
Martinez S; Looker DL; Berens RL; Marr JJ
Am J Trop Med Hyg; 1988 Sep; 39(3):250-5. PubMed ID: 2845824
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of mesoionic compounds in Leishmania sp. and toxicity evaluation.
Rodrigues RF; da Silva EF; Echevarria A; Fajardo-Bonin R; Amaral VF; Leon LL; Canto-Cavalheiro MM
Eur J Med Chem; 2007 Jul; 42(7):1039-43. PubMed ID: 17367894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
